Longaeva Partners »

Onkure Therapeutics Inc-a shares owned by Longaeva Partners

Quarter-by-quarter ownership of Onkure Therapeutics Inc-a (OKUR) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Onkure Therapeutics Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Onkure Therapeutics Inc-a held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Onkure Therapeutics Inc-a by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $549k 121k 4.56

More positions owned by Longaeva Partners

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Goldman Sachs Put Option (GS)
JPMorgan Chase & Co. (JPM)
Select Sector Spdr Tr St Str Care Etf Call Option (XLV)
Bank of America Corporation (BAC)
Pfizer Call Option (PFE)
Boston Scientific Corporation Call Option (BSX)
Fifth Third Ban (FITB)
Huntington Bancshares Incorporated (HBAN)
Moody's Corporation (MCO)
Mettler-Toledo International (MTD)
Lpl Financial Holdings (LPLA)
Us Bancorp Com New (USB)
Morgan Stanley Com New (MS)

View all positions for Longaeva Partners

Top funds holding Onkure Therapeutics Inc-a

RA Capital Management
BVF
Acorn Capital Advisors
StepStone
ADAR1 Capital Management
Vivo Capital
Vestal Point Capital
BlackRock
Trails Edge Capital Partners
Vanguard Capital Management
Adage Capital Partners GP
Citadel Advisors
Sio Capital Management
Prosight Management
Logos Global Management

View all funds holding Onkure Therapeutics Inc-a